Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Clin Cancer Res. 2013 Sep 1;19(17):4599-610. doi: 10.1158/1078-0432.CCR-12-3675. Epub 2013 Jul 11.
Gastrokine 1 (GKN1) functions to protect the gastric antral mucosa and promotes healing by facilitating restoration and proliferation after injury. GKN1 is downregulated in Helicobacter pylori-infected gastric epithelial cells and loss of GKN1 expression is closely associated with gastric carcinogenesis, but underlying mechanisms of the tumor-suppressing effects of GKN1 remain largely unknown.
AGS, MKN1, MKN28 gastric cancer cells and HFE-145 immortalized non-neoplastic gastric mucosal cells were transfected with GKN1 or shGKN1. We conducted molecular and functional studies of GKN1 and miR-185 and investigated the mechanisms of alteration. We also analyzed epigenetic alterations in 80 gastric cancer tissues.
Restoration of GKN1 protein suppressed gastric cancer cell growth by inducing endogenous miR-185 that directly targets epigenetic effectors DNMT1 and EZH2 in gastric cancer cells. In addition, ectopic expression of GKN1 upregulated Tip60 and downregulated HDAC1 in an miR-185-independent manner, thereby inducing cell-cycle arrest by regulating cell-cycle proteins in gastric cancer cells. Notably, GKN1 expression was inversely correlated with DNMT1 and EZH2 expression in a subset of 80 gastric cancer tissues and various gastric cancer cell lines. Interestingly, it was found that GKN1 exerted a synergistic anti-cancerous effect with 5-fluorouracil on tumor cell growth, which suggests a possible therapeutic intervention method for gastric cancer.
Our results show that GKN1 has an miR-185-dependent and -independent mechanism for chromatic and DNA epigenetic modification, thereby regulating the cell cycle. Thus, the loss of GKN1 function contributes to malignant transformation and proliferation of gastric epithelial cells in gastric carcinogenesis.
胃泌素 1(GKN1)的功能是保护胃窦黏膜,并通过促进损伤后的修复和增殖来促进愈合。在幽门螺杆菌感染的胃上皮细胞中,GKN1 的表达下调,GKN1 表达的丧失与胃癌的发生密切相关,但 GKN1 的肿瘤抑制作用的潜在机制在很大程度上仍然未知。
AGS、MKN1、MKN28 胃癌细胞和 HFE-145 永生化非肿瘤性胃黏膜细胞转染 GKN1 或 shGKN1。我们对 GKN1 和 miR-185 进行了分子和功能研究,并研究了其改变的机制。我们还分析了 80 例胃癌组织中的表观遗传改变。
GKN1 蛋白的恢复通过诱导内源性 miR-185 抑制胃癌细胞生长,miR-185 直接靶向胃癌细胞中的表观遗传效应物 DNMT1 和 EZH2。此外,GKN1 的异位表达以 miR-185 非依赖性方式上调 Tip60 并下调 HDAC1,从而通过调节胃癌细胞中的细胞周期蛋白来诱导细胞周期停滞。值得注意的是,在 80 例胃癌组织和各种胃癌细胞系的一部分中,GKN1 的表达与 DNMT1 和 EZH2 的表达呈负相关。有趣的是,发现 GKN1 与 5-氟尿嘧啶对肿瘤细胞生长具有协同抗癌作用,这表明胃癌可能有新的治疗干预方法。
我们的结果表明,GKN1 具有 miR-185 依赖和非依赖的染色质和 DNA 表观遗传修饰机制,从而调节细胞周期。因此,GKN1 功能的丧失导致胃上皮细胞的恶性转化和增殖在胃癌的发生中。